61
Participants
Start Date
August 31, 2009
Primary Completion Date
June 30, 2012
Study Completion Date
August 31, 2012
Botulinum Toxin Type A
OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1.
Placebo (saline)
Saline injected into the prostate on Day 1.
Los Angeles
Lead Sponsor
Allergan
INDUSTRY